USFDA approval for Empagliflozin Tablets:
Ahmedabad-based Zydus Lifesciences facility gets US Food and Drug Administration (USFDA) approval for Empagliflozin tablets. The product got approval for 2 different strengths 10mg and 20mg.
The tablets are used to lower the blood sugar level in Type-II diabetes patients. It also helps to reduce stroke risk, heart attack, and death in Type-II diabetes patients.
Also Read:
- Zydus Get a USFDA nod for antifungal medication
- Dr.Reddys launched a generic version of Nexavar (Sorafenib)
- Glenmark gets USFDA nod Successfully for this drug
- What is clinical trial in pharma?
- What is Phase 0 clinical trial in pharma
- What is Phase 1 clinical trial in pharma?
- How to prepare 0.1N HCl in pharma
- Preparation and standardization of 1N NaOH as per USP
YT channel: Pharmabeejpro